Fundraising Fox

NOVOS

Founded 2018 · 34 employees on LinkedIn · 5 known investors

NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.

BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness

Founders & leadership

NOVOS was founded in 2018 by Chris Mirabile.

CM
Chris MirabileFounder & CEO

Investors · 5

Cornucopian Capital ManagementMontclair
Fab Co-Creation Studio VenturesSan Francisco · $250K – $1Mvia Odile Roujol · inferred
Resolute VenturesSan Francisco · $1M
Remagine VenturesreportedTel Aviv
UNCOMMON DENOMINATORreportedNew York

In the news

Fortnite training platform NOVOS raises $6m in fundingesportsinsider.com · Apr 2022NOVOS raises $6 million Seed round to train gamers | Ctechcalcalistech.com · Apr 2022NOVOS Closes $3.15M, Aims to Extend Healthy Human Lifespan With Science-Based Supplementsbusinesswire.com · Oct 2021

Frequently asked questions

What does NOVOS do?
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
Who founded NOVOS?
NOVOS was founded by Chris Mirabile in 2018.
Who are NOVOS's investors?
NOVOS's investors include Cornucopian Capital Management, Fab Co-Creation Studio Ventures, Resolute Ventures, Remagine Ventures, UNCOMMON DENOMINATOR.